Resource

Why should we genomically profile our patients? A clinician’s perspective.

Why should we genomically profile our patients? A clinician’s perspective.

Resource Type: Video

Why should we genomically profile our patients? A clinician’s perspective.

Provider: North Thames GLH, South East GLH

Level: Cancer MDTs

Cost: Free

Duration: 10 minutes

Date Updated: 29 September 2022

In this presentation aimed at Cancer MDTs, Dr Nirupa Murugaesu provides an overview of the process of Next Generation Sequencing testing in cancer through the Genomic Laboratory Hubs and the benefits this can offer for patients.

Dr Murugaesu is a Consultant Medical Oncologist at St George’s University Hospitals NHS Foundation Trust and Cancer Lead for Genomics, South East GLH.

This was recorded in September 2022 as part of the Bayer sponsored educational event Everything you want to know about genomics but are afraid to ask, which explored the benefits and challenges of mainstreaming genomic profiling and precision oncology pathways in the management of patients with cancer.

You can view the other presentations from the meeting by following the links below;